Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023

BUY
$0.0 - $9.95 $0 - $152,772
15,354 New
15,354 $0
Q2 2021

Aug 05, 2021

SELL
$9.91 - $12.78 $935,573 - $1.21 Million
-94,407 Closed
0 $0
Q1 2021

Apr 21, 2021

SELL
$10.44 - $12.22 $1.21 Million - $1.42 Million
-116,253 Reduced 55.19%
94,407 $1 Million
Q4 2020

Jan 21, 2021

SELL
$9.3 - $11.77 $16,368 - $20,715
-1,760 Reduced 0.83%
210,660 $2.29 Million
Q3 2020

Oct 13, 2020

SELL
$7.59 - $10.8 $140,794 - $200,340
-18,550 Reduced 8.03%
212,420 $2.06 Million
Q2 2019

Jul 22, 2019

BUY
$9.32 - $12.98 $510,270 - $710,655
54,750 Added 31.07%
230,970 $2.16 Million
Q1 2019

Apr 17, 2019

BUY
$10.35 - $13.06 $899,311 - $1.13 Million
86,890 Added 97.27%
176,220 $2.16 Million
Q4 2018

Jan 23, 2019

BUY
$11.64 - $15.41 $1.04 Million - $1.38 Million
89,330 New
89,330 $1.06 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.